- Combined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway
Yeliz Ekici et al, 2021, Medical Oncology CrossRef - The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation
Amber Blaauboer et al, 2022, Biomedicines CrossRef - The Immune Microenvironment in Pancreatic Cancer
Magdalena Huber et al, 2020, International Journal of Molecular Sciences CrossRef - NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy
Dominik Schmiedel et al, 2018, Frontiers in Immunology CrossRef - Leveraging NKG2D Ligands in Immuno-Oncology
Mercedes Beatriz Fuertes et al, 2021, Frontiers in Immunology CrossRef - Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors.
null Roca et al, 2019, Journal of Clinical Medicine CrossRef